Fingerprint
Dive into the research topics of 'Corrigendum: A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically